Physician profile
Jonathan A Hoda
NPI 1053519785
$12,945.69
in general payments reported to CMS, 2019-2025
44 companies · $2,149 in 2025
The $2,149 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,162 · 2020: $262 · 2021: $687 · 2022: $4,224 · 2023: $1,928 · 2024: $2,533 · 2025: $2,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,578 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,577.71 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,756.41 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $1,020.77 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $933.05 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $865.86 | 2022-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $831.21 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $829.20 | 2020-2025 | Watchman Flx, Cds - Mct/Cem Monitoring, Watchman Access System |
| Pfizer INC. | $714.80 | 2019-2025 | |
| Novo Nordisk INC | $697.50 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $676.46 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $374.75 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $367.46 | 2019-2025 | Farxiga |
| Abbott Laboratories | $317.96 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Coronary, Cardiomems |
| Abiomed | $220.48 | 2019-2025 | |
| Lexicon Pharmaceuticals, INC. | $218.39 | 2023-2024 | Inpefa |
| Alnylam Pharmaceuticals INC. | $209.30 | 2024-2025 | Onpattro |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $196.77 | 2022-2025 | Alphavac |
| Philips North America LLC | $183.76 | 2022-2025 | (Ck4) Mcot, Ecc Solutions, Mcot |
| Edwards Lifesciences Corporation | $174.73 | 2022-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $129.68 | 2022-2023 | Arcalyst |
| Astellas Pharma US INC | $128.05 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $97.69 | 2023-2024 | |
| Esperion Therapeutics, INC. | $93.70 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.88 | 2024-2025 | |
| Shockwave Medical, INC | $82.21 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $76.18 | 2022-2023 | Cobalt Dr Mri Surescan |
| Cardiovascular Systems INC. | $71.32 | 2022-2023 | Diamondback Coronary |
| Cardiva Medical, INC. | $58.63 | 2025 | Optowire |
| Vital Connect, INC | $54.43 | 2023-2024 | Vitalpatch Rtm |
| Actelion Pharmaceuticals US, INC. | $52.95 | 2021-2022 | |
| Amarin Pharma, INC. | $47.13 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $42.74 | 2024 | Arcalyst |
| Surmodics, INC. | $39.09 | 2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight |
| Daiichi Sankyo INC. | $36.87 | 2019-2022 | |
| Lundbeck LLC | $32.46 | 2019 | |
| Lilly USA, LLC | $31.73 | 2023-2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $29.65 | 2025 | Verquvo |
| Inspire Medical Systems, INC. | $25.13 | 2025 | Inspire |
| Hologic Sales and Service, LLC | $25.10 | 2023 | Aptima |
| Catheter Precision INC. | $24.63 | 2024 | |
| Thrombolex, INC. | $22.42 | 2025 | Bashir Endovascular Catheter |
| Glaxosmithkline, LLC. | $19.23 | 2025 | Shingrix, Arexvy |
| Acist Medical Systems, INC. | $18.91 | 2022 | |
| Penumbra, INC. | $15.00 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Hoda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.